Outlook Therapeutics, Inc. (OTLK)
0.6723
+0.03
(+5.39%)
USD |
NASDAQ |
Sep 15, 16:00
0.678
+0.01
(+0.85%)
After-Hours: 17:36
Outlook Therapeutics Price : 0.6723 for Sept. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | 0.6543 | 0.6688 | 0.6316 | 0.6379 | 2.848M |
| Sep 11, 2026 | 0.67 | 0.68 | 0.65 | 0.66 | 3.334M |
| Sep 10, 2026 | 0.6348 | 0.67 | 0.626 | 0.6612 | 3.112M |
| Sep 09, 2026 | 0.6397 | 0.6452 | 0.621 | 0.6439 | 2.676M |
| Sep 08, 2026 | 0.6577 | 0.67 | 0.6325 | 0.6405 | 4.806M |
| Sep 04, 2026 | 0.6599 | 0.6962 | 0.6451 | 0.6665 | 6.396M |
| Sep 03, 2026 | 0.6217 | 0.6652 | 0.6174 | 0.649 | 6.641M |
| Sep 02, 2026 | 0.62 | 0.64 | 0.6043 | 0.6263 | 4.607M |
| Sep 01, 2026 | 0.63 | 0.6408 | 0.6145 | 0.6231 | 3.580M |
| Aug 31, 2026 | 0.631 | 0.664 | 0.6276 | 0.6334 | 6.431M |
| Aug 28, 2026 | 0.65 | 0.6586 | 0.6191 | 0.6449 | 9.495M |
| Aug 27, 2026 | 0.643 | 0.675 | 0.6355 | 0.6411 | 6.853M |
| Aug 26, 2026 | 0.64 | 0.6589 | 0.6231 | 0.6233 | 6.063M |
| Aug 25, 2026 | 0.615 | 0.6847 | 0.6115 | 0.64 | 15.95M |
| Aug 24, 2026 | 0.6223 | 0.6405 | 0.59 | 0.609 | 14.80M |
| Aug 21, 2026 | 0.6759 | 0.706 | 0.64 | 0.6472 | 11.50M |
| Aug 20, 2026 | 0.6901 | 0.716 | 0.6647 | 0.6763 | 8.670M |
| Aug 19, 2026 | 0.7078 | 0.7181 | 0.6705 | 0.6901 | 20.76M |
| Aug 18, 2026 | 0.6722 | 0.7039 | 0.602 | 0.70 | 41.04M |
| Aug 17, 2026 | 0.7954 | 0.7975 | 0.67 | 0.6722 | 80.66M |
| Aug 14, 2026 | 0.8438 | 0.8438 | 0.712 | 0.7564 | 104.62M |
| Aug 13, 2026 | 0.769 | 0.8918 | 0.7602 | 0.8888 | 82.39M |
| Aug 12, 2026 | 1.12 | 1.18 | 1.07 | 1.10 | 8.070M |
| Aug 11, 2026 | 1.15 | 1.158 | 1.09 | 1.13 | 6.090M |
| Aug 10, 2026 | 1.00 | 1.18 | 0.995 | 1.15 | 10.31M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Valion Bio, Inc. | 2.12 |
| Agenus, Inc. | 7.17 |
| Amgen, Inc. | 375.66 |
| Anika Therapeutics, Inc. | 20.88 |
| BioCryst Pharmaceuticals, Inc. | 8.16 |
Price Related Metrics
| PS Ratio | 122.39 |
| Earnings Yield | -168.3% |
| Market Cap | 125.79M |